Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary intervention - Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary intervention

Hirosaki University Graduate School of Medicine0 个研究点目标入组 300 人开始时间: 2014年7月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)Patients who developed acute myocardial infarction within 30days from percutaneous coronary intervention (2)Patinets who had been treated with percutaneous coronary intervention (3)Patients treated with fibrate-based medicine (4)Patients treated with hemodyalysis (5)Patients diagnosed with familial hypercholesterolemia (6)Patients who developed stroke within 3 months from percutaneous coronary intervention (7)Patients having liver damage (8)Patients having renal damage (9)Patients having high level of serum creatine phosphokinase (10)Patients treated with cyclosporin (11)Pregnant patients (12)Patients with hypothyroidism or muscular disorder (13)Drug abuse and alcoholic patients (14)Patients having carcinoma (15)Patients having severe complications (16)Patients having allergy of rosuvastatin or atorvastatin

发起方

Hirosaki University Graduate School of Medicine